<?xml version="1.0" encoding="iso-8859-1"?><!-- Copy and paste the url into your newsreader application" -->
<rss version="2.0" 
  xmlns:dc="http://purl.org/dc/elements/1.1/"
  xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
  xmlns:admin="http://webns.net/mvcb/"
  xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#">
<channel>
	<title>About.com <![CDATA[Biotech / Biomedical]]></title>
	<link>http://biotech.about.com/</link>
	<description>Get the latest headlines from the About.com <![CDATA[Biotech / Biomedical GuideSite.]]></description>
	<image>
		<title>About.com</title>
		<url>http://clk.about.com/?zi=1/1hh</url> 
		<link>http://www.about.com/</link> 
		<width>118</width> 
		<height>20</height> 
	</image>
	<dc:language>en-us</dc:language>
	<dc:creator></dc:creator>
	<dc:date>2011-05-23T18:46:37Z</dc:date>
	<pubDate>Mon, 23 May 2011 18:46:37 +0000</pubDate>
	<admin:generatorAgent rdf:resource="" />
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<sy:updateBase>2000-01-01T12:00+00:00</sy:updateBase>
	
			<item>
			<title>Types of RNA</title>
			<link>http://biotech.about.com/b/2011/05/26/types-of-rna.htm</link>
			<description>&lt;p&gt;Lots of new research is being done using &lt;a href=&quot;http://clk.about.com/?zi=1/1hc&amp;#038;zu=http://biotech.about.com/od/glossary/g/Mi-rna.htm&quot;&gt;miRNA&lt;/a&gt; and &lt;a href=&quot;http://clk.about.com/?zi=1/1hc&amp;#038;zu=http://biotech.about.com/od/glossary/g/siRNA.htm&quot;&gt;siRNA&lt;/a&gt;, as small molecule treatments for various diseases. As a result, these small RNA pieces have become very popular topics in biotech, but for those of you who aren't all that familiar with the nucleic acids, there are three major types of RNA within cells. The micro/si RNAs come from one of them, called messenger RNA (mRNA).&amp;#160;Here's the lowdown on the three types of larger RNA particles:&lt;/p&gt;...&lt;p&gt;&lt;a href=&quot;http://clk.about.com/?zi=1/1hc&amp;#038;zu=http://biotech.about.com/b/2011/05/26/types-of-rna.htm&quot;&gt;Read Full Post&lt;/a&gt;&lt;/p&gt;</description>
			<guid isPermaLink="true">http://biotech.about.com/b/2011/05/26/types-of-rna.htm</guid>
			<dc:subject></dc:subject>
			<pubDate>Thu, 26 May 2011 07:37:29 +0000</pubDate>
			<dc:date>2011-05-26T07:37:29Z</dc:date>

		</item>
			<item>
			<title>Small Molecule Halts Drug-Resistant Leukemia</title>
			<link>http://biotech.about.com/b/2011/05/23/small-molecules-halts-drug-resistant-leukemia.htm</link>
			<description>&lt;p&gt;The &lt;strong&gt;BCL6&lt;/strong&gt; protein is a &lt;a href=&quot;http://clk.about.com/?zi=1/1hc&amp;#038;zu=http://biotech.about.com/od/proteinengineering/f/transcriptfact.htm&quot;&gt;transcription factor&lt;/a&gt; known to be active in many different kinds of cancer, one of which is drug-resistant &lt;strong&gt;acute lymphoblastic leukemia (ALL)&lt;/strong&gt;. ALL is the most common form of cancer among children. Many children survive ALL, but a subset suffer from drug-resistance, the cause of which was, until now, a mystery. This week, however, a research team in California (&lt;a href=&quot;http://clk.about.com/?zi=1/1hc&amp;#038;zu=http://www.chla.org/site/c.ipINKTOAJsG/b.3763823/&quot;&gt;Children's Hospital Los Angeles&lt;/a&gt; and &lt;a href=&quot;http://clk.about.com/?zi=1/1hc&amp;#038;zu=http://www.ucsf.edu/&quot;&gt;University of California San Francisco&lt;/a&gt;) published work that shows the investigational drug &lt;strong&gt;RI-BPI&lt;/strong&gt;, when administered along with the traditional treatment for ALL, &lt;strong&gt;Gleevec&lt;/strong&gt;, can shut down ALL by inhibiting BCL6.&lt;/p&gt;...&lt;p&gt;&lt;a href=&quot;http://clk.about.com/?zi=1/1hc&amp;#038;zu=http://biotech.about.com/b/2011/05/23/small-molecules-halts-drug-resistant-leukemia.htm&quot;&gt;Read Full Post&lt;/a&gt;&lt;/p&gt;</description>
			<guid isPermaLink="true">http://biotech.about.com/b/2011/05/23/small-molecules-halts-drug-resistant-leukemia.htm</guid>
			<dc:subject></dc:subject>
			<pubDate>Mon, 23 May 2011 18:46:37 +0000</pubDate>
			<dc:date>2011-05-23T18:46:37Z</dc:date>

		</item>
			<item>
			<title>High-Sensitivity Assays Detect New Cancer Biomarkers</title>
			<link>http://biotech.about.com/b/2011/05/20/high-sensitivity-assays-detect-new-cancer-biomarkers.htm</link>
			<description>&lt;p&gt;&lt;img src=&quot;http://0.tqn.com/d/biotech/1/0/W/0/-/-/nanosphere.jpg&quot; border=&quot;0&quot; alt=&quot;&quot; hspace=&quot;5&quot; width=&quot;200&quot; height=&quot;80&quot; align=&quot;right&quot; /&gt;&lt;/p&gt;

&lt;p&gt;&lt;a href=&quot;http://clk.about.com/?zi=1/1hc&amp;#038;zu=http://www.nanosphere.us/&quot;&gt;Nanosphere Inc.&lt;/a&gt; is a &lt;a href=&quot;http://clk.about.com/?zi=1/1hc&amp;#038;zu=http://biotech.about.com/od/glossary/g/Nanotech.htm&quot;&gt;nanotechnology&lt;/a&gt;-based developer of diagnostic systems,&amp;#160;including molecular systems, for detecting disease. Their discovery program has resulted in the identification of a number of cancer &lt;a href=&quot;http://clk.about.com/?zi=1/1hc&amp;#038;zu=http://biotech.about.com/od/faq/f/bioindicators.htm&quot;&gt;biomarkers&lt;/a&gt; that are only detectable using their ultra-sensitive, high-throughput protein assays. The protein biomarkers detect bladder, prostate and kidney cancers. Nanosphere will present their research, using the&amp;#160;&lt;strong&gt;Verisens(TM)&lt;/strong&gt; assay for detection of the proteins, at the &lt;a href=&quot;http://clk.about.com/?zi=1/1hc&amp;#038;zu=http://chicago2011.asco.org/&quot;&gt;American Society of Clinical Oncology (ASCO) Annual Meeting&lt;/a&gt; next week.&lt;/p&gt;...&lt;p&gt;&lt;a href=&quot;http://clk.about.com/?zi=1/1hc&amp;#038;zu=http://biotech.about.com/b/2011/05/20/high-sensitivity-assays-detect-new-cancer-biomarkers.htm&quot;&gt;Read Full Post&lt;/a&gt;&lt;/p&gt;</description>
			<guid isPermaLink="true">http://biotech.about.com/b/2011/05/20/high-sensitivity-assays-detect-new-cancer-biomarkers.htm</guid>
			<dc:subject></dc:subject>
			<pubDate>Fri, 20 May 2011 07:08:29 +0000</pubDate>
			<dc:date>2011-05-20T07:08:29Z</dc:date>

		</item>
			<item>
			<title>Harvard Bioscience Tops Boston Globe's "Best-of" List</title>
			<link>http://biotech.about.com/b/2011/05/19/harvard-bioscience-tops-boston-globes-best-of-list.htm</link>
			<description>&lt;p&gt;Just last month (April 24th) I wrote a &lt;a href=&quot;http://clk.about.com/?zi=1/1hc&amp;#038;zu=http://biotech.about.com/b/2011/04/24/bioartificial-organs-becoming-reality.htm&quot;&gt;blog about Harvard Bioscience Inc.&lt;/a&gt; and their specialized bioreactor and protocol for making hollow organs to transplant into humans. Last Friday, President David Green reported that the &quot;&lt;em&gt;strong track record for growth and profitability&lt;/em&gt;&quot; of the company had been recognized by the &lt;a href=&quot;http://clk.about.com/?zi=1/1hc&amp;#038;zu=http://www.boston.com/bostonglobe/&quot;&gt;Boston Globe&lt;/a&gt;, which named Harvard Bioscience the #1 biotech company in the Massachusetts area.&amp;#160;Harvard Bioscience has been in business since 1901, surviving the Great Recession, and continues today as a powerful force in life sciences research. The company is affiliated with &lt;a href=&quot;http://clk.about.com/?zi=1/1hc&amp;#038;zu=http://hms.harvard.edu/hms/home.asp&quot;&gt;Harvard Medical School&lt;/a&gt; and provides &lt;a href=&quot;http://clk.about.com/?zi=1/1hc&amp;#038;zu=http://biotech.about.com/od/glossary/g/regenerativemed.htm&quot;&gt;regenerative medicine&lt;/a&gt; devices to hospitals that allow surgeons to perform&amp;#160;cutting-edge procedures.&lt;/p&gt;...&lt;p&gt;&lt;a href=&quot;http://clk.about.com/?zi=1/1hc&amp;#038;zu=http://biotech.about.com/b/2011/05/19/harvard-bioscience-tops-boston-globes-best-of-list.htm&quot;&gt;Read Full Post&lt;/a&gt;&lt;/p&gt;</description>
			<guid isPermaLink="true">http://biotech.about.com/b/2011/05/19/harvard-bioscience-tops-boston-globes-best-of-list.htm</guid>
			<dc:subject></dc:subject>
			<pubDate>Thu, 19 May 2011 21:44:00 +0000</pubDate>
			<dc:date>2011-05-19T21:44:00Z</dc:date>

		</item>
			<item>
			<title>Rosetta Green Has Solutions to Drought and Biofuel Concerns</title>
			<link>http://biotech.about.com/b/2011/05/16/rosetta-green-has-solutions-to-drought-and-biofuel-concerns.htm</link>
			<description>&lt;p&gt;&lt;strong&gt;RGN-131&lt;/strong&gt; is part of a family of &lt;a href=&quot;http://clk.about.com/?zi=1/1hc&amp;#038;zu=http://biotech.about.com/od/glossary/g/Mi-rna.htm&quot;&gt;miRNA&lt;/a&gt; genes discovered by a company called &lt;a href=&quot;http://clk.about.com/?zi=1/1hc&amp;#038;zu=http://www.rosettagreen.com/&quot;&gt;Rosetta Green Ltd.&lt;/a&gt; that play a role in drought tolerance in plants. Rosetta Green is a publically-traded company based in Isreal. It is a 2010 spin-off of a company called &lt;a href=&quot;http://clk.about.com/?zi=1/1hc&amp;#038;zu=http://www.rosettagenomics.com/&quot;&gt;Rosetta Genomics Ltd.&lt;/a&gt;, and just went public, completing an &lt;a href=&quot;http://clk.about.com/?zi=1/1hc&amp;#038;zu=http://biotech.about.com/od/glossary/g/IPO.htm&quot;&gt;IPO&lt;/a&gt; in Tel Aviv this past February.&lt;/p&gt;...&lt;p&gt;&lt;a href=&quot;http://clk.about.com/?zi=1/1hc&amp;#038;zu=http://biotech.about.com/b/2011/05/16/rosetta-green-has-solutions-to-drought-and-biofuel-concerns.htm&quot;&gt;Read Full Post&lt;/a&gt;&lt;/p&gt;</description>
			<guid isPermaLink="true">http://biotech.about.com/b/2011/05/16/rosetta-green-has-solutions-to-drought-and-biofuel-concerns.htm</guid>
			<dc:subject></dc:subject>
			<pubDate>Mon, 16 May 2011 21:28:39 +0000</pubDate>
			<dc:date>2011-05-16T21:28:39Z</dc:date>

		</item>
			<item>
			<title>Who Wants to Live Forever?</title>
			<link>http://biotech.about.com/b/2011/05/15/who-wants-to-live-forever.htm</link>
			<description>&lt;p&gt;Yesterday morning I caught a large part of a National Geographic television show on the aging process and longevity. The show followed the quest of a guy, who looked not a whole lot younger than me (don't ask!!), on a mission to find the secret to everlasting youth. Research by several genetic scientists was highlighted, as they explained the links between research&amp;#160;using &lt;a href=&quot;http://clk.about.com/?zi=1/1hc&amp;#038;zu=http://biotech.about.com/b/2009/03/12/what-is-a-drosophila.htm&quot;&gt;drosophila&lt;/a&gt; and nematodes, stem cells and &lt;a href=&quot;http://clk.about.com/?zi=1/1hc&amp;#038;zu=http://biotech.about.com/od/proteinengineering/f/transcriptfact.htm&quot;&gt;transcription factors&lt;/a&gt;, among other things, and our understanding of how our cells and bodies age.&lt;/p&gt;...&lt;p&gt;&lt;a href=&quot;http://clk.about.com/?zi=1/1hc&amp;#038;zu=http://biotech.about.com/b/2011/05/15/who-wants-to-live-forever.htm&quot;&gt;Read Full Post&lt;/a&gt;&lt;/p&gt;</description>
			<guid isPermaLink="true">http://biotech.about.com/b/2011/05/15/who-wants-to-live-forever.htm</guid>
			<dc:subject></dc:subject>
			<pubDate>Sun, 15 May 2011 19:28:17 +0000</pubDate>
			<dc:date>2011-05-15T19:28:17Z</dc:date>

		</item>
			<item>
			<title>Localized Immunosuppression of Islet Transplants Using Stem Cells</title>
			<link>http://biotech.about.com/b/2011/05/13/localized-immunosuppression-of-islet-transplants-using-stem-cells.htm</link>
			<description>&lt;p&gt;One of the drawbacks to organ transplants, or even stem cell treatments, like &lt;a href=&quot;http://clk.about.com/?zi=1/1hc&amp;#038;zu=http://biotech.about.com/od/glossary/g/TherapeuticClon.htm&quot;&gt;therapeutic cloning&lt;/a&gt;, can be the necessity&amp;#160;for &lt;strong&gt;immunosuppressent drugs&lt;/strong&gt;, which patients wind up having to take for the rest of their lives, or risk rejection of the transplanted cells/organ. Needless to say, this compromises the immune systems, and can create other potential health risks, for these&amp;#160;individuals. &lt;strong&gt;Cell replacement therapy&lt;/strong&gt; is a medical approach to neurological, muscular and other disorders wherein dead or defective cells are replaced with new ones. The need for immunosupressent drugs&amp;#160;creates limitations&amp;#160;to the use of this approach, but&amp;#160;scientists&amp;#160;in the UK are working on&amp;#160;the problem with respect to&amp;#160;&lt;strong&gt;pancreatic islet transplantation&lt;/strong&gt; for people with &lt;a href=&quot;http://clk.about.com/?zi=1/1hc&amp;#038;zu=http://biotech.about.com/od/glossary/g/type1diabetes.htm&quot;&gt;diabetes&lt;/a&gt;. They are using human &lt;strong&gt;amniotic epithelial cells (AEC)&lt;/strong&gt; to generate a localized anti-inflammatory and immunosuppressent effect, in the region of islet cell transplants, by&amp;#160;creating cellular constructs that combine&amp;#160;the two types of&amp;#160;cells. This reseach has the potential to eliminate (or at least reduce) the need for systemic immunosuppression in the future.&lt;/p&gt;...&lt;p&gt;&lt;a href=&quot;http://clk.about.com/?zi=1/1hc&amp;#038;zu=http://biotech.about.com/b/2011/05/13/localized-immunosuppression-of-islet-transplants-using-stem-cells.htm&quot;&gt;Read Full Post&lt;/a&gt;&lt;/p&gt;</description>
			<guid isPermaLink="true">http://biotech.about.com/b/2011/05/13/localized-immunosuppression-of-islet-transplants-using-stem-cells.htm</guid>
			<dc:subject></dc:subject>
			<pubDate>Fri, 13 May 2011 07:19:24 +0000</pubDate>
			<dc:date>2011-05-13T07:19:24Z</dc:date>

		</item>
			<item>
			<title>In Defense of Cloning and Stem Cells</title>
			<link>http://biotech.about.com/b/2011/05/12/in-defense-of-cloning-and-stem-cells.htm</link>
			<description>&lt;p&gt;&lt;a href=&quot;http://clk.about.com/?zi=1/1hc&amp;#038;zu=http://biotech.about.com/od/labtechniques/g/What-Is-A-Clone.htm&quot;&gt;Cloning&lt;/a&gt; and stem cell research often get a bad rap because the words conjure up images of human experiments gone wrong coupled with the destruction of embryos. However, if you know anything about stem cell research, you this doesn't necessarily &lt;strong&gt;need&lt;/strong&gt; to be the case. In fact,&amp;#160;harvesting stem cells for medical use, and cloning them, is part of the widely accepted practice of bone marrow transplantation. Adult stem cells from blood and muscle might be used to generate other types of cells, like neural cells, for &lt;a href=&quot;http://clk.about.com/?zi=1/1hc&amp;#038;zu=http://biotech.about.com/od/glossary/g/regenerativemed.htm&quot;&gt;regenerative medicine&lt;/a&gt;, the potential of which is exemplified in the blog I posted&amp;#160;two weeks ago on bioartificial organs made using a patient's own cells.&amp;#160; By the way - which would you rather have...an organ grown from your own stem cells, or an animal organ given to you via &lt;a href=&quot;http://clk.about.com/?zi=1/1hc&amp;#038;zu=http://biotech.about.com/od/glossary/g/Xenotransplant.htm&quot;&gt;xenotransplantation&lt;/a&gt;?&lt;/p&gt;...&lt;p&gt;&lt;a href=&quot;http://clk.about.com/?zi=1/1hc&amp;#038;zu=http://biotech.about.com/b/2011/05/12/in-defense-of-cloning-and-stem-cells.htm&quot;&gt;Read Full Post&lt;/a&gt;&lt;/p&gt;</description>
			<guid isPermaLink="true">http://biotech.about.com/b/2011/05/12/in-defense-of-cloning-and-stem-cells.htm</guid>
			<dc:subject></dc:subject>
			<pubDate>Thu, 12 May 2011 20:32:52 +0000</pubDate>
			<dc:date>2011-05-12T20:32:52Z</dc:date>

		</item>
			<item>
			<title>US Military and Vical Continue DNA Vaccine Collaboration</title>
			<link>http://biotech.about.com/b/2011/05/11/us-military-and-vical-continue-dna-vaccine-collaboration.htm</link>
			<description>&lt;p&gt;&lt;img src=&quot;http://0.tqn.com/d/biotech/1/0/V/0/-/-/Vical.jpg&quot; border=&quot;0&quot; alt=&quot;Vical Inc.&amp;#169;Vical Incorporated&quot; hspace=&quot;5&quot; width=&quot;150&quot; height=&quot;60&quot; align=&quot;right&quot; /&gt;&lt;/p&gt;

&lt;p&gt;Awhile ago I wrote a piece about &lt;a href=&quot;http://clk.about.com/?zi=1/1hc&amp;#038;zu=http://biotech.about.com/od/researchdevelopments/a/Inovio-Pharma.htm&quot;&gt;Inovio Pharmaceuticals&lt;/a&gt; and their in situ electroporation platform for delivering DNA vaccines. CEO Dr. Joseph Kim, in an &lt;a href=&quot;http://clk.about.com/?zi=1/1hc&amp;#038;zu=http://biotech.about.com/od/researchdevelopments/a/JosephKim.htm&quot;&gt;interview&lt;/a&gt;, said he believed they had found the answer to DNA vaccine delivery, and that gave his company the advantage over everyone else. Well, watch out Dr. Kim, because you're not the only one who thinks you've found the secret to optimal DNA vaccine expression within human cells.&lt;/p&gt;...&lt;p&gt;&lt;a href=&quot;http://clk.about.com/?zi=1/1hc&amp;#038;zu=http://biotech.about.com/b/2011/05/11/us-military-and-vical-continue-dna-vaccine-collaboration.htm&quot;&gt;Read Full Post&lt;/a&gt;&lt;/p&gt;</description>
			<guid isPermaLink="true">http://biotech.about.com/b/2011/05/11/us-military-and-vical-continue-dna-vaccine-collaboration.htm</guid>
			<dc:subject></dc:subject>
			<pubDate>Wed, 11 May 2011 07:39:46 +0000</pubDate>
			<dc:date>2011-05-11T07:39:46Z</dc:date>

		</item>
			<item>
			<title>Women in Bio Networking Event</title>
			<link>http://biotech.about.com/b/2011/05/09/women-in-bio-networking-event.htm</link>
			<description>&lt;p&gt;&lt;a href=&quot;http://clk.about.com/?zi=1/1hc&amp;#038;zu=http://www.womeninbio.org/about-wib.shtml&quot;&gt;Women in Bio (WIB)&lt;/a&gt; is an&amp;#160;American&amp;#160;organization that is quickly spreading across the country with a mandate to support &quot;careers, leadership and entrepreneurship of women in the life sciences&quot;. Chapters of this organization,&amp;#160;which was established in&amp;#160;2001, are opening in all the major &lt;a href=&quot;http://clk.about.com/?zi=1/1hc&amp;#038;zu=http://biotech.about.com/od/introtobiotechnology/tp/NAclusters.htm&quot;&gt;biotechnology clusters&lt;/a&gt; in the USA.&amp;#160;This provides women and youth in the industry a great opportunity to meet, share ideas, knowledge and experience.&lt;/p&gt;...&lt;p&gt;&lt;a href=&quot;http://clk.about.com/?zi=1/1hc&amp;#038;zu=http://biotech.about.com/b/2011/05/09/women-in-bio-networking-event.htm&quot;&gt;Read Full Post&lt;/a&gt;&lt;/p&gt;</description>
			<guid isPermaLink="true">http://biotech.about.com/b/2011/05/09/women-in-bio-networking-event.htm</guid>
			<dc:subject></dc:subject>
			<pubDate>Mon, 09 May 2011 18:29:15 +0000</pubDate>
			<dc:date>2011-05-09T18:29:15Z</dc:date>

		</item>
	</channel>

</rss>

